Characterization of invasive Group B Streptococcus isolates from Western Australian infants, 2004–2020

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Group B streptococcal disease in infants 0–3 months in The Netherlands, 1987–2023: a nationwide genomic and epidemiological surveillance study2026
2. 2Invasive Streptococcus agalactiae infections in infants in Guangzhou, Southern China (2013–2022): molecular epidemiology and clinical management implications2026
3. 3Molecular genetic determinants of virulence of Streptococcus agalactiae isolated from pregnant women and newborns in St. Petersburg and the Leningrad region in 2010–20232024 · 1 citations
4. 4Prevalence of candidate vaccine targets and genomic features of pediatric invasive <i>Streptococcus agalactiae</i> in Japan2025
5. 5Population structure of human Group B Streptococcus in Brazil: vaccine targets, sequence types, and antimicrobial resistance markers2026